These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32998177)

  • 1. Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.
    Nettis E; Fabbrocini G; Ortoncelli M; Pellacani G; Argenziano G; Di Leo E; Patruno C; Stingeni L; Foti C; Rongioletti F; Macchia L; Tavecchio S; Napolitano M; Ribero S; Bonzano L; Calabrese G; Di Bona D; Nisticò SP; Hansel K; Romita P; Piras V; Carbonara M; Detoraki A; Ferrucci SM
    Br J Dermatol; 2021 Mar; 184(3):561-563. PubMed ID: 32998177
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
    Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
    Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry".
    Seo HM; Oh SU; Park SK; Kim JS
    J Am Acad Dermatol; 2021 Sep; 85(3):e171. PubMed ID: 33667539
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
    Bosma AL; de Wijs LEM; Hof MH; van Nieuwenhuizen BR; Gerbens LAA; Middelkamp-Hup MA; Hijnen D; Spuls PI
    J Am Acad Dermatol; 2021 Sep; 85(3):e173-e174. PubMed ID: 33675862
    [No Abstract]   [Full Text] [Related]  

  • 5. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis.
    Kato A; Kamata M; Ito M; Uchida H; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Sep; 47(9):1013-1019. PubMed ID: 32548920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis.
    Agache I; Akdis CA; Akdis M; Brockow K; Chivato T; Del Giacco S; Eiwegger T; Eyerich K; Giménez-Arnau A; Gutermuth J; Guttman-Yassky E; Maurer M; Ogg G; Ong PY; O'Mahony L; Schwarze J; Warner A; Werfel T; Palomares O; Jutel M
    Allergy; 2021 Apr; 76(4):988-1009. PubMed ID: 33538044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data.
    de Wijs LEM; Bosma AL; Erler NS; Hollestein LM; Gerbens LAA; Middelkamp-Hup MA; Kunkeler ACM; Nijsten TEC; Spuls PI; Hijnen DJ
    Br J Dermatol; 2020 Feb; 182(2):418-426. PubMed ID: 31145810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
    Ribero S; Giura MT; Viola R; Ramondetta A; Siliquini N; Cardone P; Tonella L; Quaglino P; Dapavo P; Panzone M; Ortoncelli M; Fierro MT
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e380-e383. PubMed ID: 31960496
    [No Abstract]   [Full Text] [Related]  

  • 12. Dupilumab for the Treatment of Atopic Dermatitis.
    Ferreira S; Torres T
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):230-240. PubMed ID: 29422431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
    Hendricks AJ; Yosipovitch G; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
    [No Abstract]   [Full Text] [Related]  

  • 14. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
    Bosma AL; Spuls PI; Garcia-Doval I; Naldi L; Prieto-Merino D; Tesch F; Apfelbacher CJ; Arents BWM; Barbarot S; Baselga E; Deleuran M; Eichenfield LF; Gerbens LAA; Irvine AD; Manca A; Mendes-Bastos P; Middelkamp-Hup MA; Roberts A; Seneschal J; Svensson Å; Thyssen JP; Torres T; Vermeulen FM; Vestergaard C; von Kobyletzki LB; Wall D; Weidinger S; Schmitt J; Flohr C
    Br J Dermatol; 2020 Jun; 182(6):1423-1429. PubMed ID: 31444799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients.
    Harada K; Irisawa R; Ito T; Uchiyama M; Tsuboi R
    Br J Dermatol; 2020 Aug; 183(2):396-397. PubMed ID: 32118289
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyenthesitis during treatment with dupilumab for atopic dermatitis.
    Ishibashi M; Honda T; Tabuchi Y; Kabashima K
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e319-e321. PubMed ID: 31991016
    [No Abstract]   [Full Text] [Related]  

  • 17. Dupilumab improved atypical fibrotic skin plaques in atopic dermatitis.
    Nakashima C; Ishida Y; Kaku Y; Epstein EH; Otsuka A; Kabashima K
    Br J Dermatol; 2020 Feb; 182(2):487-488. PubMed ID: 31325158
    [No Abstract]   [Full Text] [Related]  

  • 18. New-onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis.
    Bax CE; Khurana MC; Treat JR; Castelo-Soccio L; Rubin AI; McMahon PJ
    Pediatr Dermatol; 2021 Mar; 38(2):390-394. PubMed ID: 33426747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
    Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
    Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
    [No Abstract]   [Full Text] [Related]  

  • 20. Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients.
    Wang Y; Jorizzo J
    Int J Dermatol; 2021 Sep; 60(9):e382. PubMed ID: 33715168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.